Statement of the DOG, RG and BVA on Anti-VEGF Therapy in neovascular age-related Macular Degeneration

被引：0
作者：
机构：
[1] Deutsch Ophthalmol Gesell, Platenstr 1, D-80336 Munich, Germany
[2] Retinol Gesell eV, Freiburg, Germany
[3] Berufsverband Augenarzte Deutschlands eV, Dusseldorf, Germany
来源：
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE | 2020年 / 237卷 / 08期
关键词：
ENDOTHELIAL GROWTH-FACTOR; RANIBIZUMAB TREATMENT; CLINICAL BURDEN; VISUAL-ACUITY; PLAN REGIMEN; OUTCOMES; TREAT; EFFICACY; VERTEPORFIN; BEVACIZUMAB;
D O I：
10.1055/a-1191-1433
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：995 / 1003
页数：9
相关论文
共 54 条
  • [1] ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION A Treat-and-Extend Protocol Over 2 Years
    Abedi, Farshad
    Wickremasinghe, Sanjeewa
    Islam, Amirul F. M.
    Inglis, Kellie M.
    Guymer, Robyn H.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (08): : 1531 - 1538
  • [2] [Anonymous], 2011, Ophthalmologe, V1, P86
  • [3] [Anonymous], 2017, OPHTHALMOLOGE, V114, P220
  • [4] [Anonymous], 2015, Ophthalmologe, V112, P237
  • [5] [Anonymous], 2013, KLIN MONBL AUGENHEIL, V230, P170
  • [6] [Anonymous], 2011, Klin. Monbl. Augenheilkd., V228, P138
  • [7] [Anonymous], 2013, OPHTHALMOLOGE, V110, P405
  • [8] [Anonymous], 2009, Klin. Monbl. Augenheilkd., V226, P388
  • [9] [Anonymous], 2012, OPHTHALMOLOGE, V109, P405
  • [10] [Anonymous], 2017, KLIN MONATSBL AUGENH, V234, P650
123456